Sleeping pills linked to higher risk of cancer, death, study says

A new study suggests that the 6% to 10% of Americans who use prescription sleep medications such as zolpidem (Ambien), temazepam (Restoril), eszopiclone (Lunesta) and zaleplon (Sonata) are more likely to develop cancer, and far more likely to die prematurely, than those who take no sleep aids.

By Melissa Healy, Los Angeles Times/For the Booster Shots Blog

February 28, 2012